This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations. In February 2019, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address this issue.
#Cgm findings professional
Although unified recommendations for use of key CGM metrics have been established in three separate peer-reviewed articles, formal adoption by diabetes professional organizations and guidance in the practical application of these metrics in clinical practice have been lacking. This may be due in part to the lack of clear and agreed-upon glycemic targets that both diabetes teams and people with diabetes can work toward. However, successful utilization of CGM technology in routine clinical practice remains relatively low. Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). Weinzimer, Moshe Phillip Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Parkin, Eric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Hirsch, Roman Hovorka, Weiping Jia, Olga Kordonouri, Boris Kovatchev, Aaron Kowalski, Lori Laffel, Brian Levine, Alexander Mayorov, Chantal Mathieu, Helen R. Doyle, Satish Garg, George Grunberger, Simon Heller, Lutz Heinemann, Irl B. Close, Claudio Cobelli, Eyal Dassau, J. Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A. Over one year, I will complete three discrete studies to address my research question.Tadej Battelino, Thomas Danne, Richard M. I aim to generate scientific evidence to tailor support and resources for effective CGM use in older adults with T1D.
“My overarching hypothesis is that delivering CGM to older adults with T1D demands new approaches that consider a breadth of different individual-level needs for patient-oriented ‘onboarding’ and use in daily life. However, not all older adults use CGM right now. The findings of that study suggested that CGM may offer life-saving benefits for older adults. In a study of older adults, in which half of the participants were randomized to use CGM for six months, CGM reduced hypoglycemia. Compared to self-monitoring with intermittent finger sticks and a glucometer, CGM offers greater insight into current glucose levels and trends, in addition to notifications for out-of-range readings and alarms for low glucose levels. Thus, much of diabetes care and management in older adulthood is focused around avoiding these dangerous episodes of hypoglycemia.ĬGM is a new, technologic approach to glucose monitoring that transmits real-time or near real-time glucose readings from an on-body sensor to a small device. As individuals age, both the risk for and the danger of low blood sugar (i.e. There is a growing population of older adults (defined as adults who are 65 years of age or older) with T1D. With $50K in funding from the Diabetics Research Connection, early career researcher and Assistant Professor of Nutrition Anna Kahkoska, MD, PhD, will study a new approach to continuous glucose monitoring (CGM) that could be especially helpful for older adults with Type 1 diabetes (T1D). Khakoska receives funding to study new approach to T1D glucose monitoring The award winner will be awarded $5,000 and be invited to give a presentation at the Annual Meeting. In particular, he is interested in infectious diseases, primarily HIV and birth outcomes.” These study designs include randomized experiments and observational studies.
“He is interested in study designs and analyses that accurately estimate parameters of central interest to population-health scientists. Cole works to build robust, accurate, and impactful knowledge at the intersection of epidemiology and statistics,” SER stated. The prestigious Marshall Joffe Epidemiologic Methods Research Award is given annually to recognize outstanding accomplishments in developing, adapting, or translating a methodological concept or approach whose usefulness has been demonstrated through fruitful adoption in epidemiology, including applied population health research settings. Stephen Cole, PhD, professor of epidemiology, has received the 2022 Marshall Joffe Epidemiologic Methods Research Award from the Society for Epidemiologic Research (SER).
0 kommentar(er)
